Regen BioPharma RGBP
OTC RGBP
$0.00 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Regen BioPharma Inc (RGBP) Consolidated Net Income (2013 - 2026)

Updated

Regen BioPharma's Consolidated Net Income came in at -$637,785 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$167,292 a year earlier.

Analysis

Regen BioPharma Inc (RGBP) Consolidated Net Income (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Regen BioPharma reported Consolidated Net Income of -$2.35 million; for FY2025 (ended Sep 30, 2025), it was -$1.27 million.

  • Going back by fiscal year, Consolidated Net Income was -$668,255 in FY2024, $1.16 million in FY2023, -$477,870 in FY2022 and -$516,784 in FY2021.
  • The five-year range for quarterly Consolidated Net Income is -$967,853 (fiscal Q1 2026) to -$19,354 (fiscal Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -637,785.00
Dec 31, 2025 -967,853.00
Sep 30, 2025 -572,469.00
Jun 30, 2025 -167,292.00
Mar 31, 2025 -19,354.00
Dec 31, 2024 -515,384.00
Sep 30, 2024 -270,748.00
Jun 30, 2024 -130,120.00
Mar 31, 2024 -122,454.00
Dec 31, 2023 -144,913.00
Sep 30, 2023 -74,164.00
Jun 30, 2023 -99,218.00
Mar 31, 2023 -90,927.00
Dec 31, 2022 -481,226.00
Sep 30, 2022 -128,529.00
Jun 30, 2022 -89,309.00
Mar 31, 2022 -119,055.00
Dec 31, 2021 -141,432.00
Sep 30, 2021 -244,810.00
Jun 30, 2021 -102,060.00
API Access

Regen BioPharma Inc Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=RGBP&period=max&api_key=YOUR_API_KEY